Antigen-specific therapy of rheumatoid arthritis (Q57674015)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

review article

1 reference

title

Antigen-specific therapy of rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

Xiufen Zheng

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Motohiko Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Norihiko Kubo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Xusheng Zhang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Lisa R Min

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Marianne E Beduhn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Neil H Riordan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Wei-Ping Min

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

English

0 references

publication date

1 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

191-199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Reactivation of latent tuberculosis by TNF blockade: the role of interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Drug-induced lupus after treatment with infliximab in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Autoimmune epitopes: autoepitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Citrullinated proteins in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T cells in human arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Type II collagen autoimmunity in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Autoimmunity to type II collagen an experimental model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Immunotherapy in collagen-induced arthritis: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Oral tolerance: therapeutic implications for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

IL-10-producing T regulatory type 1 cells and oral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Cell cycle block in anergic T cells during tolerance induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

A double-blind clinical trial for treatment of Crohn's disease by oral administration of Alequel, a mixture of autologous colon-extracted proteins: a patient-tailored approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Oral Tolerance and Pyruvate Dehydrogenase in Patients with Primary Biliary Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Oral tolerance in autoimmune uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Autoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Evidence for multiple shared antigenic determinants within Ro60 and other lupus-related ribonucleoprotein autoantigens in human autoimmune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Antigen-specific therapies for the treatment of multiple sclerosis: a clinical trial update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Heat shock proteins (HSP) for immunotherapy of rheumatoid arthritis (RA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Threshold signaling of human Th0 cells in activation and anergy: modulation of effector function by altered TCR ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Regulation of T cell activation and tolerance by PDL2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Mini ReviewFLT3: Receptor and Ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Flt3 in regulation of type I interferon-producing cell and dendritic cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Dendritic cells as antigen presenting cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Regulatory activity of autocrine IL-10 on dendritic cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Generation of dendritic cells with regulatory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

LF15-0195 generates tolerogenic dendritic cells by suppression of NF-kappaB signaling through inhibition of IKK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

LF 15-0195 generates synergistic tolerance by promoting formation of CD4+CD25+CTLA4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Clinical research. Death prompts a review of gene therapy vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

TNF downmodulates the function of human CD4+CD25hi T-regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.191

21 January 2018

Identifiers

DOI

10.1517/14712598.8.2.191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194075%20AND%20SRC:MED&resulttype=core&format=json